The association of neuropsychiatric symptoms in MCI with incident dementia and alzheimer disease

Paul B. Rosenberg, Michelle M Mielke, Brian S. Appleby, Esther S. Oh, Yonas Endale Geda, Constantine G. Lyketsos

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Objectives: Individuals with mild cognitive impairment (MCI) are at high risk of developing dementia and/or Alzheimer disease (AD). Among persons with MCI, depression and anxiety have been associated with an increased risk of incident dementia. We examined whether neuropsychiatric symptoms in MCI increased the risk of incident dementia (all-cause) and incident AD. Design: Longitudinal cohort study followed annually (median: 1.58 years). Setting: National Alzheimer's Coordinating Center database combining clinical data from 29 Alzheimer's Disease Centers. Participants: A total of 1,821 participants with MCI. Measurements: 1) Progression to dementia (all-cause) or AD, 2) Neuropsychiatric Inventory Questionnaire (NPI-Q), 3) Geriatric Depression Scale (GDS), 4) Clinical Dementia Rating Global Score and Sum of Boxes, and 5) Mini-Mental State Examination (MMSE). The association of covariates with risk of incident dementia or AD was evaluated with hazard ratios (HR) determined by Cox proportional-hazards models adjusted for age, ethnicity, Clinical Dementia Rating Global Score and Sum of Boxes, and MMSE. Results: A total of 527 participants (28.9%) progressed to dementia and 454 (24.9%) to AD. Baseline GDS > 0 was associated with an increased risk of incident dementia (HR: 1.47, 95% CI: 1.17-1.84) and AD (HR: 1.45, 95% CI: 1.14-1.83). Baseline NPI > 0 was associated with an increased risk of incident dementia (HR: 1.37, 95% CI: 1.12-1.66) and AD (HR: 1.35, 95% CI: 1.09-1.66). Conclusions: Neuropsychiatric symptoms in MCI are associated with significantly an increased risk of incident dementia and AD. Neuropsychiatric symptoms may be among the earliest symptoms of preclinical stages of AD and targeting them therapeutically might delay transition to dementia.

Original languageEnglish (US)
Pages (from-to)685-695
Number of pages11
JournalAmerican Journal of Geriatric Psychiatry
Volume21
Issue number7
DOIs
StatePublished - 2013

Fingerprint

Dementia
Alzheimer Disease
Depression
Geriatrics
Cognitive Dysfunction
Proportional Hazards Models
Longitudinal Studies
Cohort Studies
Anxiety
Databases
Equipment and Supplies

Keywords

  • Alzheimer disease
  • Dementia
  • Depression
  • Longitudinal study
  • Mild cognitive impairment
  • Neuropsychiatric symptoms

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

The association of neuropsychiatric symptoms in MCI with incident dementia and alzheimer disease. / Rosenberg, Paul B.; Mielke, Michelle M; Appleby, Brian S.; Oh, Esther S.; Geda, Yonas Endale; Lyketsos, Constantine G.

In: American Journal of Geriatric Psychiatry, Vol. 21, No. 7, 2013, p. 685-695.

Research output: Contribution to journalArticle

Rosenberg, Paul B. ; Mielke, Michelle M ; Appleby, Brian S. ; Oh, Esther S. ; Geda, Yonas Endale ; Lyketsos, Constantine G. / The association of neuropsychiatric symptoms in MCI with incident dementia and alzheimer disease. In: American Journal of Geriatric Psychiatry. 2013 ; Vol. 21, No. 7. pp. 685-695.
@article{7af96186439f49098c456e84e4c719b7,
title = "The association of neuropsychiatric symptoms in MCI with incident dementia and alzheimer disease",
abstract = "Objectives: Individuals with mild cognitive impairment (MCI) are at high risk of developing dementia and/or Alzheimer disease (AD). Among persons with MCI, depression and anxiety have been associated with an increased risk of incident dementia. We examined whether neuropsychiatric symptoms in MCI increased the risk of incident dementia (all-cause) and incident AD. Design: Longitudinal cohort study followed annually (median: 1.58 years). Setting: National Alzheimer's Coordinating Center database combining clinical data from 29 Alzheimer's Disease Centers. Participants: A total of 1,821 participants with MCI. Measurements: 1) Progression to dementia (all-cause) or AD, 2) Neuropsychiatric Inventory Questionnaire (NPI-Q), 3) Geriatric Depression Scale (GDS), 4) Clinical Dementia Rating Global Score and Sum of Boxes, and 5) Mini-Mental State Examination (MMSE). The association of covariates with risk of incident dementia or AD was evaluated with hazard ratios (HR) determined by Cox proportional-hazards models adjusted for age, ethnicity, Clinical Dementia Rating Global Score and Sum of Boxes, and MMSE. Results: A total of 527 participants (28.9{\%}) progressed to dementia and 454 (24.9{\%}) to AD. Baseline GDS > 0 was associated with an increased risk of incident dementia (HR: 1.47, 95{\%} CI: 1.17-1.84) and AD (HR: 1.45, 95{\%} CI: 1.14-1.83). Baseline NPI > 0 was associated with an increased risk of incident dementia (HR: 1.37, 95{\%} CI: 1.12-1.66) and AD (HR: 1.35, 95{\%} CI: 1.09-1.66). Conclusions: Neuropsychiatric symptoms in MCI are associated with significantly an increased risk of incident dementia and AD. Neuropsychiatric symptoms may be among the earliest symptoms of preclinical stages of AD and targeting them therapeutically might delay transition to dementia.",
keywords = "Alzheimer disease, Dementia, Depression, Longitudinal study, Mild cognitive impairment, Neuropsychiatric symptoms",
author = "Rosenberg, {Paul B.} and Mielke, {Michelle M} and Appleby, {Brian S.} and Oh, {Esther S.} and Geda, {Yonas Endale} and Lyketsos, {Constantine G.}",
year = "2013",
doi = "10.1016/j.jagp.2013.01.006",
language = "English (US)",
volume = "21",
pages = "685--695",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - The association of neuropsychiatric symptoms in MCI with incident dementia and alzheimer disease

AU - Rosenberg, Paul B.

AU - Mielke, Michelle M

AU - Appleby, Brian S.

AU - Oh, Esther S.

AU - Geda, Yonas Endale

AU - Lyketsos, Constantine G.

PY - 2013

Y1 - 2013

N2 - Objectives: Individuals with mild cognitive impairment (MCI) are at high risk of developing dementia and/or Alzheimer disease (AD). Among persons with MCI, depression and anxiety have been associated with an increased risk of incident dementia. We examined whether neuropsychiatric symptoms in MCI increased the risk of incident dementia (all-cause) and incident AD. Design: Longitudinal cohort study followed annually (median: 1.58 years). Setting: National Alzheimer's Coordinating Center database combining clinical data from 29 Alzheimer's Disease Centers. Participants: A total of 1,821 participants with MCI. Measurements: 1) Progression to dementia (all-cause) or AD, 2) Neuropsychiatric Inventory Questionnaire (NPI-Q), 3) Geriatric Depression Scale (GDS), 4) Clinical Dementia Rating Global Score and Sum of Boxes, and 5) Mini-Mental State Examination (MMSE). The association of covariates with risk of incident dementia or AD was evaluated with hazard ratios (HR) determined by Cox proportional-hazards models adjusted for age, ethnicity, Clinical Dementia Rating Global Score and Sum of Boxes, and MMSE. Results: A total of 527 participants (28.9%) progressed to dementia and 454 (24.9%) to AD. Baseline GDS > 0 was associated with an increased risk of incident dementia (HR: 1.47, 95% CI: 1.17-1.84) and AD (HR: 1.45, 95% CI: 1.14-1.83). Baseline NPI > 0 was associated with an increased risk of incident dementia (HR: 1.37, 95% CI: 1.12-1.66) and AD (HR: 1.35, 95% CI: 1.09-1.66). Conclusions: Neuropsychiatric symptoms in MCI are associated with significantly an increased risk of incident dementia and AD. Neuropsychiatric symptoms may be among the earliest symptoms of preclinical stages of AD and targeting them therapeutically might delay transition to dementia.

AB - Objectives: Individuals with mild cognitive impairment (MCI) are at high risk of developing dementia and/or Alzheimer disease (AD). Among persons with MCI, depression and anxiety have been associated with an increased risk of incident dementia. We examined whether neuropsychiatric symptoms in MCI increased the risk of incident dementia (all-cause) and incident AD. Design: Longitudinal cohort study followed annually (median: 1.58 years). Setting: National Alzheimer's Coordinating Center database combining clinical data from 29 Alzheimer's Disease Centers. Participants: A total of 1,821 participants with MCI. Measurements: 1) Progression to dementia (all-cause) or AD, 2) Neuropsychiatric Inventory Questionnaire (NPI-Q), 3) Geriatric Depression Scale (GDS), 4) Clinical Dementia Rating Global Score and Sum of Boxes, and 5) Mini-Mental State Examination (MMSE). The association of covariates with risk of incident dementia or AD was evaluated with hazard ratios (HR) determined by Cox proportional-hazards models adjusted for age, ethnicity, Clinical Dementia Rating Global Score and Sum of Boxes, and MMSE. Results: A total of 527 participants (28.9%) progressed to dementia and 454 (24.9%) to AD. Baseline GDS > 0 was associated with an increased risk of incident dementia (HR: 1.47, 95% CI: 1.17-1.84) and AD (HR: 1.45, 95% CI: 1.14-1.83). Baseline NPI > 0 was associated with an increased risk of incident dementia (HR: 1.37, 95% CI: 1.12-1.66) and AD (HR: 1.35, 95% CI: 1.09-1.66). Conclusions: Neuropsychiatric symptoms in MCI are associated with significantly an increased risk of incident dementia and AD. Neuropsychiatric symptoms may be among the earliest symptoms of preclinical stages of AD and targeting them therapeutically might delay transition to dementia.

KW - Alzheimer disease

KW - Dementia

KW - Depression

KW - Longitudinal study

KW - Mild cognitive impairment

KW - Neuropsychiatric symptoms

UR - http://www.scopus.com/inward/record.url?scp=85027941701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027941701&partnerID=8YFLogxK

U2 - 10.1016/j.jagp.2013.01.006

DO - 10.1016/j.jagp.2013.01.006

M3 - Article

AN - SCOPUS:85027941701

VL - 21

SP - 685

EP - 695

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 7

ER -